By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
MARKET CLOSE: NZ shares plunge after Brexit vote; Xero, A2, banks hit hard
NZ dollar, swaps tumble as Brexit confounds pollsters; central banks likely to act
Fronde chairman Jon Mayson ousted, two other directors also exit
NZ interest rates plunge as Brexit gets closer to reality
Smiths City annual profit drops 30%, sales rise as retailer ditches low-margin business
Cavalier raises 2016 earnings guidance on better performance from broadloom carpets
NZ stocks turn as UK referendum result keeps investors guessing
Update: APN and NZME pay $36.3 million to settle disputed tax avoidance and other cases
Ryman board seeks 9% pay rise to cope with bigger business
NZ dollar spikes then drops in illiquid market as UK results dribble in